ConductScience.org, home
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
API referenceFor AI assistants

Trial · NCT02853305

Adverse events1,750

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,750

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) First Course227349334
otherAnaemiaBlood and lymphatic system disordersPembrolizumab (Pembro) First Course75302103
otherAnaemiaBlood and lymphatic system disordersST Chemotherapy (Chemo) First Course210342303
otherAnaemiaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) Second Course0140
otherAnaemiaBlood and lymphatic system disordersPembrolizumab (Pembro) Second Course0150
otherLeukopeniaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) First Course3134960
otherLeukopeniaBlood and lymphatic system disordersPembrolizumab (Pembro) First Course03020
otherLeukopeniaBlood and lymphatic system disordersST Chemotherapy (Chemo) First Course2534255
otherLeukopeniaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) Second Course0140
otherLeukopeniaBlood and lymphatic system disordersPembrolizumab (Pembro) Second Course0150
otherNeutropeniaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) First Course126349274
otherNeutropeniaBlood and lymphatic system disordersPembrolizumab (Pembro) First Course23022
otherNeutropeniaBlood and lymphatic system disordersST Chemotherapy (Chemo) First Course129342281
otherNeutropeniaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) Second Course0140
otherNeutropeniaBlood and lymphatic system disordersPembrolizumab (Pembro) Second Course0150
otherThrombocytopeniaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) First Course86349175
otherThrombocytopeniaBlood and lymphatic system disordersPembrolizumab (Pembro) First Course23022
otherThrombocytopeniaBlood and lymphatic system disordersST Chemotherapy (Chemo) First Course89342180
otherThrombocytopeniaBlood and lymphatic system disordersPembrolizumab + ST Chemotherapy (Pembro Combo) Second Course0140
otherThrombocytopeniaBlood and lymphatic system disordersPembrolizumab (Pembro) Second Course0150

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02853305/events

API referenceFor AI assistants